Unknown PHASE1 INTERVENTIONAL 2-arm NCT02122042

Hyperbaric Oxygen Therapy Can Improve Cognitive Deficits Post Low Grade Glioma Removal Surgery

Hyperbaric Oxygen Therapy Can Improve Cognitive Deficits Post Low Grade Glioma Removal Surgery - Randomized Prospective Trial

Sponsor: Assaf-Harofeh Medical Center

Conditions Cognitive Deficits Post Low Grade Glioma Surgery

Interventions HBOT

Updated 6 times since 2017 Last updated: Apr 22, 2014 Started: May 31, 2014 Primary completion: May 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Cognitive Deficits and Post Low Grade Glioma Surgery, this trial is ongoing. The trial is conducted by Assaf-Harofeh Medical Center and has accumulated 6 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE1
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2017 — Jan 2021 [monthly]

Unknown Status PHASE1

Status: Not Yet Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Jun 2017 [monthly]

Not Yet Recruiting PHASE1

First recorded

May 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assaf-Harofeh Medical Center

Data source: Assaf-Harofeh Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ẕerifin, Israel